Observational studyArchives of Razi Institute2024
COVID-19 Vaccination Adverse Events in Children: An Investigation with a Control Group in Tabriz Metropolitan City.
Observational study in Archives of Razi Institute, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The attitude of the unvaccinated children's parents toward pediatric COVID-19 vaccination in Tabriz, Iran.BMC pediatrics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The occurrence of adverse events following vaccination with the novel coronavirus disease 2019 (COVID-19) vaccine in children remains somewhat unclear, with only a limited number of population-based studies having been conducted in this age group. The objective of this study is to ascertain the short-term adverse events associated with the Sinopharm and Soberana (Pasto CoVac) vaccination in children between the ages of 5 and 12. This study employs an observational design with a control group. The cluster sampling method was employed to recruit the study samples, with healthcare centers and mass vaccination centers of Tabriz designated as clusters. The ratio of the vaccinated and unvaccinated groups was 2:1, respectively. Information was gathered via telephone interviews with the parents or guardians of the subjects. The data were analyzed using a mixed-effect logistic regression model. In this study, a total of 913 children were investigated, comprising 577 vaccinated and 336 unvaccinated children. The results demonstrated that the most frequent complication among the vaccinated children was injection site pain, occurring in 178 cases (30.8%, 95% CI:( 27%, 35%)) The most frequently reported systemic adverse events among vaccinated and unvaccinated children were fever (9.0% vs. 3.6%, p = 0.003), fatigue (5.5% vs. 0.9%, p = 0.002), and headache (2.9% vs. 0.6%, p = 0.032). No serious adverse events, including myocarditis, multisystem inflammatory syndrome (MIS), or hospitalization, were reported. The odds of experiencing any symptoms in the vaccinated group, adjusted for potential confounding variables, were significantly higher than in the control group (adjusted OR = 4.71, CI 95%: (3.04, 7.26), with a p-value of less than 0.001. The results indicate that the Sinopharm and Soberana (PastoCoVac) vaccines did not have any serious adverse effects. Moreover, it appears that some of the reported adverse events in other studies may be overestimated due to the absence of a control group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.